Cleveland, OHNCT06133387Now EnrollingIRB Ready

Colorectal Lesion Clinical Trial in Cleveland, OH

Access cutting-edge colorectal lesion treatment through this clinical trial at a research site in Cleveland. Study-provided care at no cost to qualified participants.

Sponsored by EndoQuest Robotics, Inc.

Quick Self-Assessment

See if you qualify for this Cleveland location

Preparing your pre-screening questions…

Expert Care in Cleveland

Access colorectal lesion specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related colorectal lesion treatment provided free

Apply for This Cleveland Location

Check if you qualify for this colorectal lesion clinical trial in Cleveland, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cleveland

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cleveland site if eligible
  4. 4Begin participation

About This Colorectal Lesion Study in Cleveland

The objective of this study is to evaluate the safety and effectiveness of the Endoluminal Surgical (ELS) System in subjects undergoing specified transanal endoluminal procedures in the rectum and sigmoid colon. Subjects will undergo endoscopic submucosal dissection (ESD), with or without closure at the discretion of the Investigator, of benign lesions in the rectum and sigmoid colon. The safety and effectiveness outcomes will be assessed intraoperatively and postoperatively at discharge and Days 7 and 30.

Sponsor: EndoQuest Robotics, Inc.

Who Can Participate

Inclusion Criteria

Subject is ≥22 years at the time of consent.
Subject has a BMI ≤ 50 kg/m2.
Subject has an ASA score of ≤ 3.
Subject has benign lesion(s) of the rectum or sigmoid colon, such as adenoma (with low- or high-grade dysplasia), neuroendocrine tumor, or other type of polyp as assessed by the most recent colonoscopy/flexible sigmoidoscopy.
Subject has lesion ≤ 7 cm in size (dimension of greatest extent) and ≤ 75% of the colorectal circumference as assessed by the most recent colonoscopy/flexible sigmoidoscopy.
Subject is eligible for standard endoscopic submucosal dissection.
Subject agrees to participate in the study by giving signed informed consent. Preoperative

Exclusion Criteria

Subject anatomy is unsuitable for endoscopic visualization or endoluminal surgery.
Subject has active left-sided inflammatory bowel disease.
Subject has an untreated active infection at the time of the procedure.
Subject is considered part of a vulnerable population (e.g., prisoners, mentally disabled).
Subject has a severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic interventions (e.g., cancer).
Subject is breastfeeding or pregnant or intends to become pregnant during the study.
Subject is currently enrolled in or discontinued within the last 30 days from a clinical trial of an investigational drug or device, or concurrently enrolled in any other type of medical research judged not to be scientifically or medically compatible with this study.
Subject with EF ≤ 45, high cardiac or high pulmonary risk (these subjects require clearance from a cardiologist and pulmonologist, as applicable).
Subject on preoperative blood thinners, such as coumadin or heparin, that cannot be weaned prior to surgery.
Subject is moderately or severely immunocompromised.
In the opinion of the Investigator, the subject is unable to comply with the requirements of the study protocol or is unsuitable for the study for any reason. Intraoperative Exclusion Criteria (assessed with third-party endoscope):
Inadequate bowel prep.
Complex anatomical findings not feasible for an endoluminal approach.
Anatomical narrowing distal to the lesion site.
Lesion not located in the rectum or sigmoid colon.
Lesion size \>7 cm (dimension of greatest extent) or occupies \>75% of the colorectal circumference.
Lesion demonstrates characteristics indicative of invasive carcinoma, such as failure to lift upon submucosal injection, or any other features that raise the Investigator's suspicion of cancer. Intraoperative Exclusion Criteria (assessed with study device):
In the opinion of the Investigator, the subject and/or subject anatomy is not suitable for study device use for any reason.
Lesion location not accessible by the study device.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cleveland?

Yes, this clinical trial (NCT06133387) has an active research site in Cleveland, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Colorectal Lesion Treatment Options in Cleveland, OH

If you're searching for colorectal lesion treatment options in Cleveland, OH, this clinical trial (NCT06133387) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cleveland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colorectal lesion specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Ready to Join in Cleveland?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cleveland, OH